I bought a SAFE instead of shares, and had to understand what that meant
There was no stock to transfer. What I actually bought was someone else's contract with the company.
Angel investor, experienced with priced-round secondaries, new to SAFEs
Illustrative composite. A representative scenario built from how angel secondaries commonly play out — realistic numbers, written in the first person, not the record of a specific named person or company.
Deal snapshot
- Side
- Buying
- Instrument
- SAFE assignment
- Original SAFE cap
- $1,000,000
- Original investment
- $25,000
- Price I paid for the assignment
- $60,000
- What converts to me
- Shares at the original $1,000,000 cap, once triggered
Expecting shares, getting a contract
I'd done a couple of secondary purchases before, always buying priced-round stock directly. This time, the seller held a SAFE that had never converted — there was no stock yet to buy. What I was actually purchasing was an assignment of their contractual position: their spot in line for whatever shares the SAFE eventually converts into.
Why the price made sense once I understood the structure
The seller had invested $25,000 at a $1,000,000 cap years earlier. The company had grown substantially since, so I paid $60,000 to take over that position — a real premium over their original check, but still a discount to what a fresh primary investment at the company's current valuation would cost, specifically because I was locking in their old, more favorable cap.
The company had to consent to the assignment, since the SAFE's own language restricted transfer without it — a separate approval step from the ROFR process I was used to on priced-stock deals.
The risk I made sure I understood
A SAFE has no guaranteed conversion date. I was buying a contractual right to future equity, not equity itself, and if the company never raises another priced round — or shuts down — that right may never convert into anything. I went in accepting that risk explicitly, which is different from how I'd thought about buying already-issued stock.
What to take from this
- Confirm whether you're buying shares or an unconverted instrument (SAFE or note) before agreeing to a price.
- A SAFE assignment requires company consent under its own transfer language, separate from a standard ROFR process.
- You're taking on real conversion-timing risk — a SAFE has no guaranteed date, and could remain outstanding indefinitely.
Every angel who has held a position long enough eventually faces a version of this decision. For the mechanics behind stories like this one, see the guide to how secondaries work.